Ovid Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
CEOJeremy Max Levin
CEOJeremy Max Levin
Employees23
Employees23
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2014
Founded2014
Employees23
Employees23
OVID Key Statistics
Market cap118.57M
Market cap118.57M
Price-Earnings ratio-3.27
Price-Earnings ratio-3.27
Dividend yield—
Dividend yield—
Average volume2.18M
Average volume2.18M
High today$1.75
High today$1.75
Low today$1.59
Low today$1.59
Open price$1.64
Open price$1.64
Volume1.41M
Volume1.41M
52 Week high$2.01
52 Week high$2.01
52 Week low$0.2425
52 Week low$0.2425
Stock Snapshot
With a market cap of 118.57M, Ovid Therapeutics(OVID) trades at $1.63. The stock has a price-to-earnings ratio of -3.27.
As of 2025-12-07, Ovid Therapeutics(OVID) stock has fluctuated between $1.59 and $1.75. The current price stands at $1.63, placing the stock +2.5% above today's low and -6.6% off the high.
Ovid Therapeutics(OVID) shares are trading with a volume of 1.41M, against a daily average of 2.18M.
During the past year, Ovid Therapeutics(OVID) stock moved between $0.24 at its lowest and $2.01 at its peak.
During the past year, Ovid Therapeutics(OVID) stock moved between $0.24 at its lowest and $2.01 at its peak.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.